Advertisement

Index by author

May 01, 2015; Volume 353,Issue 2

  1. Sakai, Yoshiki

    1. The Novel Prostaglandin I2 Mimetic ONO-1301 Escapes Desensitization in an Antiplatelet Effect Due to Its Inhibitory Action on Thromboxane A2 Synthesis in Mice
      Hitoshi Kashiwagi, Koh-ichi Yuhki, Fumiaki Kojima, Shima Kumei, Osamu Takahata, Yoshiki Sakai, Shuh Narumiya and Fumitaka Ushikubi
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 269-278; DOI: https://doi.org/10.1124/jpet.115.222612

  2. Salituro, Francesco G.

    1. VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
      Sudipta Mahajan, James K. Hogan, Dina Shlyakhter, Luke Oh, Francesco G. Salituro, Luc Farmer and Thomas C. Hoock
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 405-414; DOI: https://doi.org/10.1124/jpet.114.221176

  3. Sanchez, Jenifer

    1. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16
      Ana Ramírez de Molina, Teodoro Vargas, Susana Molina, Jenifer Sánchez, Jorge Martínez-Romero, Margarita González-Vallinas, Roberto Martín-Hernández, Ruth Sánchez-Martínez, Marta Gómez de Cedrón, Alberto Dávalos, Luca Calani, Daniele Del Rio, Antonio González-Sarrías, Juan Carlos Espín, Francisco A. Tomás-Barberán and Guillermo Reglero
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 433-444; DOI: https://doi.org/10.1124/jpet.114.221796

  4. Sanchez-martinez, Ruth

    1. The Ellagic Acid Derivative 4,4′-Di-O-Methylellagic Acid Efficiently Inhibits Colon Cancer Cell Growth through a Mechanism Involving WNT16
      Ana Ramírez de Molina, Teodoro Vargas, Susana Molina, Jenifer Sánchez, Jorge Martínez-Romero, Margarita González-Vallinas, Roberto Martín-Hernández, Ruth Sánchez-Martínez, Marta Gómez de Cedrón, Alberto Dávalos, Luca Calani, Daniele Del Rio, Antonio González-Sarrías, Juan Carlos Espín, Francisco A. Tomás-Barberán and Guillermo Reglero
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 433-444; DOI: https://doi.org/10.1124/jpet.114.221796

  5. Sawchenko, Paul E.

    1. Characterization of a Pachymedusa dacnicolor–Sauvagine Analog as a New High-Affinity Radioligand for Corticotropin-Releasing Factor Receptor Studies
      Marilyn H. Perrin, Laura A. Tan, Joan M. Vaughan, Kathy A. Lewis, Cynthia J. Donaldson, Charleen Miller, Judit Erchegyi, Jean E. Rivier and Paul E. Sawchenko
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 307-317; DOI: https://doi.org/10.1124/jpet.114.222307

  6. Schiessl, Ina Maria

    1. In Vivo Visualization of the Antialbuminuric Effects of the Angiotensin-Converting Enzyme Inhibitor Enalapril
      Ina Maria Schießl, Veronika Kattler and Hayo Castrop
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 299-306; DOI: https://doi.org/10.1124/jpet.114.222125

  7. Seillier, Alexandre

    1. Simultaneous Inhibition of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Shares Discriminative Stimulus Effects with Δ9-Tetrahydrocannabinol in Mice
      Lenka Hruba, Alexandre Seillier, Armia Zaki, Benjamin F. Cravatt, Aron H. Lichtman, Andrea Giuffrida and Lance R. McMahon
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 261-268; DOI: https://doi.org/10.1124/jpet.115.222836

  8. Sexton, Patrick M.

    1. Endogenous Allosteric Modulators of G Protein–Coupled Receptors
      Emma T. van der Westhuizen, Celine Valant, Patrick M. Sexton and Arthur Christopoulos
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 246-260; DOI: https://doi.org/10.1124/jpet.114.221606

  9. Shen, Hong

    1. Evaluation of Rosuvastatin as an Organic Anion Transporting Polypeptide (OATP) Probe Substrate: In Vitro Transport and In Vivo Disposition in Cynomolgus Monkeys
      Hong Shen, Hong Su, Tongtong Liu, Ming Yao, Gabe Mintier, Lun Li, R. Marcus Fancher, Ramaswamy Iyer, Punit Marathe, Yurong Lai and A. David Rodrigues
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 380-391; DOI: https://doi.org/10.1124/jpet.114.221804

  10. Shlyakhter, Dina

    1. VX-509 (Decernotinib) Is a Potent and Selective Janus Kinase 3 Inhibitor That Attenuates Inflammation in Animal Models of Autoimmune Disease
      Sudipta Mahajan, James K. Hogan, Dina Shlyakhter, Luke Oh, Francesco G. Salituro, Luc Farmer and Thomas C. Hoock
      Journal of Pharmacology and Experimental Therapeutics May 2015, 353 (2) 405-414; DOI: https://doi.org/10.1124/jpet.114.221176
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement